Florianópolis, SC |
99 |
53.8% |
Treitinger et al., 19993434 Treitinger A, Spada C, Silva EL, Miranda AF, Oliveira OV, Silveira MV, et al. Prevalence of serologic markers of HBV and HCV Infection in HIV-1 Seropositive Patients in Florianópolis, Brazil. Braz J Infect Dis. 1999; 3(1):1-5.
|
São Paulo, SP |
1,457 |
17.7% |
Mendes-Corrêa et al., 20014141 Mendes-Corrêa MC, Barone AA, Guastini C. Hepatitis C virus seroprevalence and risk factors among patients with HIV infection. Rev Inst Med Trop São Paulo. 2001; 43(1):15-9.
|
Rio de Janeiro, RJ |
238 |
8.9% |
Ferraz et al., 200242Ferraz GGS, Menezes JA, Gazineo JLD, Passoni LFC, Lessa MPM, Pinto PTA, et al. Prevalência de Infecção pelos vírus "B" e "C" da Hepatite (HBV e HCV) em pacientes com infecção pelo vírus B e C da Imunodeficiência Humana (HIV). Rev Médica HFSE. 2002; 36(1). Available at: http://www.hse.rj.saude.gov.br/profissional/revista/36/hepat.asp. http://www.hse.rj.saude.gov.br/profissio...
|
Campinas, SP |
232 |
53.8% |
Pavan et al., 20033535 Pavan MHP, Aoki FH, Monteiro DT, Gonçales NSL, Escanhoela CAF, Gonçales Júnior FL. Viral hepatitis in patients infected with human immunodeficiency virus. Braz J Infect Dis. 2003; 7(4):253-61.
|
Santos, SP |
495 |
36.2% |
Segurado et al., 20042121 Segurado AC, Braga P, Etzel A, Cardoso MR. Hepatitis C virus coinfection in a cohort of HIV-infected individuals from Santos, Brazil: seroprevalence and associated factors. AIDS Patient Care STDS. 2004; 18(3):135-43.
|
Londrina, PR |
784 |
21.0% |
Morimoto et al., 20052222 Morimoto HK, Caterino-De-Araujo A, Morimoto AA, Reiche EM V, Ueda LT, Matsuo T, et al. Seroprevalence and risk factors for human T cell lymphotropic virus type 1 and 2 infection in human immunodeficiency virus-infected patients attending AIDS referral center health units in Londrina and other communities in Paraná, Brazil. AIDS Res Hum Retroviruses. 2005; 21(4):256-62.
|
Manaus, AM |
704 |
5.0% |
Braga et al., 20062323 Braga WSM, da Costa Castilho M, dos Santos IC, Moura MA, Segurado AC, et al. Low prevalence of hepatitis B virus, hepatitis D virus and hepatitis C virus among patients with human immunodeficiency virus or acquired immunodeficiency syndrome in the Brazilian Amazon basin. Rev Soc Bras Med Trop. 2006; 39(6):519-22.
|
Porto Alegre, RS |
330 |
38.2% |
Tovo et al., 20062525 Tovo CV, Santos DE, Mattos AZ, Almeida PRL, Mattos AA, Santos BR. Prevalência ambulatorial em um hospital geral de marcadores para hepatites B e C em pacientes com infecção pelo vírus da imunodeficiência humana. Arq Gastroenterol. 2006; 43(2):73-6.
|
Cuiabá, MT |
1,008 |
10.9% |
Mussi et al., 20072626 Mussi AD, Pereira RA, Corrêa e Silva VA, Martins RM, Souto FJ. Epidemiological aspects of hepatitis C virus infection among HIV-infected individuals in Mato Grosso State, Central Brazil. Acta Trop. 2007; 104(2-3):116-21.
|
Botucatu, SP |
150 |
14.7% |
Corvino et al., 20074343 Corvino SM, Henriques RMS, Grotto RMT, Pardini MIMC. Co-infecção HIV/HCV em pacientes de Botucatu e região. Rev Bras Epidemiol. 2007; 10(4):537-43.
|
Belo Horizonte, MG |
824 |
9.2% |
Carmo et al., 20084444 Carmo RA, Guimarães MD, Moura AS, Neiva AM, Versiani JB, Lima LV, et al. The influence of HCV coinfection on clinical, immunological and virological responses to HAART in HIV-patients. Braz J Infect Dis. 2008; 12(3):173-9.
|
Belo Horizonte, MG |
300 |
15.7% |
Rodrigues et al., 20084545 Rodrigues Mda C, Viotti JB, Braga RF, Lourenço LFS, Antunes CM, Lambertucci JR. HIV/HCV coinfection in Infectious Disease Units in Mozambique and Brazil: a comparative study. Rev Soc Bras Med Trop. 2008; 415():518.
|
Londrina, PR |
778 |
21.0% |
Reiche et al., 20082929 Reiche EMV, Bonametti AM, Morimoto HK, Morimoto AA, Wiechemann SL, Matsuo T, et al. Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population. Int J Mol Med. 2008; 21(3):387-95.
|
São Paulo, SP |
8,019 |
12.9% |
Farias et al., 200828Farias N, Tancredi MV, Wolffenbüttel K, Tayra A. Characteristics from persons and factors associated to HIV-seropositivity at the São Paulo State testing & counseling sites, 2000 to 2007. Bol Epidemiológico Paulista. 2008; 5(60). Available at: http://www.cve.saude.sp.gov.br/agencia/bepa60_hiv.htm. http://www.cve.saude.sp.gov.br/agencia/b...
|
Recife, PE |
343 |
4.1% |
Carvalho et al., 20094646 Carvalho FH, Coêlho MR, Vilella Tde A, Silva JL, Melo HR. HIV/HCV coinfection at an university hospital in Recife, Brazil. Rev Saúde Pública. 2009; 43(1):133-9.
|
São Paulo, SP |
2,024 |
16.7% |
Mendes-Corrêa et al., 20104040 Mendes-Corrêa MC, Martins LG, Tenore S, Leite OH, Leite AG, Cavalcante AJ, et al. Barriers to treatment of hepatitis C in HIV/HCV coinfected adults in Brazil. Braz J Infect Dis. 2010; 14(3):237-41.
|
Santa Maria, RS |
250 |
31.2% |
Santos et al., 20103030 Santos KF, Vieira TB, Beck ST, Leal DBR. Alterações laboratoriais encontradas em indivíduos co-infectados pelo vírus da imunodeficiência humana (HIV) e pelo vírus da hepatite C (HCV). Rev Bras Análises Clínicas. 2010; 42(1):21-4.
|
CE |
1,291 |
25.4% |
Távora et al., 20133232 Távora LG, Hyppolito EB, Cruz JN, Portela NM, Pereira SM, Veras CM. Hepatitis B, C and HIV co-infections seroprevalence in a northeast Brazilian center. Arq Gastroenterol. 2013; 50(4):277-80.
|
Curitiba, PR |
303 |
12.9% |
Present study
|